Christilyn Graff
17Patents
8h-index
19Co-inventors
65Inventor score
Filing activity: Jul 1, 2003 → May 26, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8058406B2 | Composition comprising antibodies to LINGO or fragments thereof | Chemistry; Metallurgy | 37 | Active |
| US8147829B2 | Anti-IGR-1R antibodies and uses thereof | Chemistry; Metallurgy | 37 | Active |
| US8551476B2 | SP35 antibodies and uses thereof | Chemistry; Metallurgy | 33 | Active |
| US8425910B2 | Composition comprising antibodies to LINGO or fragments thereof | Chemistry; Metallurgy | 32 | Active |
| US9066984B2 | Sp35 antibodies and uses thereof | Chemistry; Metallurgy | 26 | Active |
| US8128926B2 | Sp35 antibodies and uses thereof | Chemistry; Metallurgy | 16 | Active |
| US7232888B2 | Antibodies against tumor surface antigens | Chemistry; Metallurgy | 13 | Expired |
| US7612178B2 | Anti-IGF-1R antibodies and uses thereof | Chemistry; Metallurgy | 10 | Active |
| US8609407B2 | Sp35 antibodies and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US7626011B2 | Antibodies against tumor surface antigens | Chemistry; Metallurgy | 5 | Active |
| US9221907B2 | Anti-GPR49 monoclonal antibodies | Chemistry; Metallurgy | 4 | Active |
| US9221906B2 | Methods of inhibiting solid tumor growth by administering GPR49 antibodies | Chemistry; Metallurgy | 4 | Active |
| US9220774B2 | Methods of treating cancer by administering anti-GPR49 antibodies | Chemistry; Metallurgy | 4 | Active |
| US9745375B2 | Compositions comprising antibodies to LINGO or fragments thereof | Chemistry; Metallurgy | 1 | Active |
| US8734795B2 | Light targeting molecules and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10196442B2 | Methods of inhibiting growth of a colon cancer tumor in a subject by administering monoclonal antibodies to G protein-coupled receptor 49 (GPR49) | Chemistry; Metallurgy | 0 | Active |
| US10598653B2 | Methods of blocking cancer stem cell growth | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.